Rebecca Arend
Assistant Professor · University of Alabama Hospital
Credentials: · · · · · ·
History
Research
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 486 citations
The Wnt/β-catenin pathway in ovarian cancer: a review
Review · Gynecologic Oncology · 2013 · First of 4 authors · Corresponding · 397 citations
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Journal of the National Comprehensive Cancer Network · 2023 · 349 citations
20 papers
18 papers
14 papers
12 papers
11 papers · 7 as a resident
11 papers
10 papers · 9 as a fellow
10 papers · 2 as a fellow
Grants
- 2026–2031
Immune Dysfunction, Social Determinants of Health, and Ovarian Cancer Outcome Differences
National Cancer Institute · R01
PI · $674.1K · University of Pittsburgh at Pittsburgh
- 2003–2024
National Cancer Institute · P50
Project lead · $175K · Johns Hopkins University
Clinical trials
- 2026–2029
Principal investigator · Not yet recruiting · Phase 1
Rebecca Arend
- 2023–2027
Principal investigator · Withdrawn · Phase 1
University of Alabama at Birmingham
- 2021–2022
CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
Principal investigator · Terminated · Phase 1
University of Alabama at Birmingham
- 2021–2028
Principal investigator · Recruiting · Phase 2
University of Alabama at Birmingham